These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22105062)

  • 1. Prescription opioid misuse: characteristics of earliest and most recent memory of hydromorphone use.
    Fulton HG; Barrett SP; Stewart SH; Macisaac C
    J Addict Med; 2012 Jun; 6(2):137-44. PubMed ID: 22105062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of rural and urban nonmedical prescription opioid users' lifetime and recent drug use.
    Young AM; Havens JR; Leukefeld CG
    Am J Drug Alcohol Abuse; 2012 May; 38(3):220-7. PubMed ID: 22211586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.
    Johnson S; MacDonald SF; Cheverie M; Myrick C; Fischer B
    Drug Alcohol Depend; 2012 Jul; 124(1-2):172-6. PubMed ID: 22265193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of nonmedical use of hydromorphone and hydrocodone:results from a national household survey.
    Smith MY; Haddox JD; Di Marino ME
    J Pain Palliat Care Pharmacother; 2007; 21(3):5-17. PubMed ID: 18032351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zopiclone misuse: an update from Dublin.
    Bannan N; Rooney S; O'connor J
    Drug Alcohol Rev; 2007 Jan; 26(1):83-5. PubMed ID: 17364840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users.
    Fischer B; Patra J; Cruz MF; Gittins J; Rehm J
    Drug Alcohol Rev; 2008 Nov; 27(6):625-32. PubMed ID: 19378446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependent opioid users assessed for methadone treatment in Otago: patterns of drug use.
    Dore GM; Hargreaves G; Niven BE
    N Z Med J; 1997 May; 110(1043):162-5. PubMed ID: 9196499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
    Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
    J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
    Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M
    Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of opioid craving over time as measured by visual analog scales.
    McMillan DE; Gilmore-Thomas K
    Drug Alcohol Depend; 1996 Mar; 40(3):235-9. PubMed ID: 8861402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.